Certara, Inc. (#CERT) Certara (NASDAQ: CERT) has partnered with NVIDIA to integrate the BioNeMo Agent Toolkit into its platform, combining AI capabilities with Certara's biosimulation software and scientific expertise to enhance research workflows across the life sciences industry. Sector: Healthcare Technology Key Highlights: 🤝 Integrated NVIDIA BioNeMo Agent Toolkit 🧬 Combines biosimulation software with AI-driven research 🔬 Supports molecular docking, protein design, and biomarker discovery ⚡ Delivers faster scientific insights for life sciences companies Why It Matters: The collaboration expands Certara's AI capabilities and strengthens its position in the growing market for AI-enabled drug research. https://www.thinksabio.com/reports/isr/CETR